Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
The architecturally significant home was completed in fall 2025. LAS VEGAS, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Blue Heron Homes and Las Vegas Sotheby’s International Realty are thrilled to announce...
-
LONDON and NEW YORK, Jan. 28, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of...
-
GBI elects Sumayyah Theron, CEO and Founder of Avant-garde Sustainable Solutions, as Chair of the GBI Board and three new Directors for 2026.
-
PharmAla inks contract with Ostfold Hospital Trust in Oslo to supply clinical trial in exchange for both cash and a data license
-
Initial AX-0810 data show no safety signals after 4 weeks of dosing and pharmacokinetics consistent with non-clinical data; Phase 1 enrollment and dosing in healthy volunteers ongoing with target...
-
Science 37 Named Finalist for 2026 SCOPE Participant Engagement and Site Innovation Awards.
-
-
Fentanyl designation Response
-
NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) -- SANDOW Companies announced that it has acquired Azure, Canada’s leading international voice in architecture and design. Azure will operate as part of...
-
First Patient Dosed with Intranasal Foralumab in Randomized, Placebo-Controlled Phase 2 TrialBuilds on Recent Evidence of Persistent Neuroinflammation in Alzheimer’s Patients Treated with Anti-Amyloid...